U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C15H16N2O
Molecular Weight 240.3003
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BENMOXIN

SMILES

CC(NNC(=O)C1=CC=CC=C1)C2=CC=CC=C2

InChI

InChIKey=BEWNZPMDJIGBED-UHFFFAOYSA-N
InChI=1S/C15H16N2O/c1-12(13-8-4-2-5-9-13)16-17-15(18)14-10-6-3-7-11-14/h2-12,16H,1H3,(H,17,18)

HIDE SMILES / InChI

Description

Benmoxin is an inhibitor of monoamine oxidase that was used as an antidepressant but now is no longer marketed.

Approval Year

Unknown
149124
Name Type Language
BENMOXINE [MI]
Preferred Name English
BENMOXIN
INN  
INN  
Official Name English
BENZOIC ACID 2-(.ALPHA.-METHYLBENZYL)HYDRAZIDE
Common Name English
benmoxin [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C667
Created by admin on Mon Mar 31 18:20:48 GMT 2025 , Edited by admin on Mon Mar 31 18:20:48 GMT 2025
Code System Code Type Description
ECHA (EC/EINECS)
231-619-6
Created by admin on Mon Mar 31 18:20:48 GMT 2025 , Edited by admin on Mon Mar 31 18:20:48 GMT 2025
PRIMARY
DRUG BANK
DB09246
Created by admin on Mon Mar 31 18:20:48 GMT 2025 , Edited by admin on Mon Mar 31 18:20:48 GMT 2025
PRIMARY
NCI_THESAURUS
C77520
Created by admin on Mon Mar 31 18:20:48 GMT 2025 , Edited by admin on Mon Mar 31 18:20:48 GMT 2025
PRIMARY
SMS_ID
100000086332
Created by admin on Mon Mar 31 18:20:48 GMT 2025 , Edited by admin on Mon Mar 31 18:20:48 GMT 2025
PRIMARY
EVMPD
SUB05720MIG
Created by admin on Mon Mar 31 18:20:48 GMT 2025 , Edited by admin on Mon Mar 31 18:20:48 GMT 2025
PRIMARY
MERCK INDEX
m68
Created by admin on Mon Mar 31 18:20:48 GMT 2025 , Edited by admin on Mon Mar 31 18:20:48 GMT 2025
PRIMARY Merck Index
WIKIPEDIA
BENMOXIN
Created by admin on Mon Mar 31 18:20:48 GMT 2025 , Edited by admin on Mon Mar 31 18:20:48 GMT 2025
PRIMARY
EPA CompTox
DTXSID0046220
Created by admin on Mon Mar 31 18:20:48 GMT 2025 , Edited by admin on Mon Mar 31 18:20:48 GMT 2025
PRIMARY
DRUG CENTRAL
3681
Created by admin on Mon Mar 31 18:20:48 GMT 2025 , Edited by admin on Mon Mar 31 18:20:48 GMT 2025
PRIMARY
ChEMBL
CHEMBL1877495
Created by admin on Mon Mar 31 18:20:48 GMT 2025 , Edited by admin on Mon Mar 31 18:20:48 GMT 2025
PRIMARY
CAS
7654-03-7
Created by admin on Mon Mar 31 18:20:48 GMT 2025 , Edited by admin on Mon Mar 31 18:20:48 GMT 2025
PRIMARY
PUBCHEM
71671
Created by admin on Mon Mar 31 18:20:48 GMT 2025 , Edited by admin on Mon Mar 31 18:20:48 GMT 2025
PRIMARY
FDA UNII
XC9FY2SGBG
Created by admin on Mon Mar 31 18:20:48 GMT 2025 , Edited by admin on Mon Mar 31 18:20:48 GMT 2025
PRIMARY
INN
2403
Created by admin on Mon Mar 31 18:20:48 GMT 2025 , Edited by admin on Mon Mar 31 18:20:48 GMT 2025
PRIMARY
ACTIVE MOIETY
Structure of BENMOXIN
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966